What is the only widely available drug that prolongs survival in patients with ALS?
•
4 min read
According to landmark clinical trials, Riluzole was associated with a statistically significant prolongation of survival for patients with Amyotrophic Lateral Sclerosis (ALS). This makes it the only widely available drug that prolongs survival in patients with ALS, a progressive neurodegenerative disease.
